BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 2432415)

  • 1. Induction of natural killer cell activity in mice by injection of indomethacin.
    Voth R; Chmielarczyk W; Storch E; Kirchner H
    Nat Immun Cell Growth Regul; 1986; 5(6):317-24. PubMed ID: 2432415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cytotoxic activity in cultures of bone marrow-derived macrophages by indomethacin.
    Voth R; Storch E; Hüller K; Kirchner H
    Eur J Immunol; 1987 Jan; 17(1):145-8. PubMed ID: 3102252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of murine natural killer cells and macrophages by 8-bromoguanosine.
    Koo GC; Jewell ME; Manyak CL; Sigal NH; Wicker LS
    J Immunol; 1988 May; 140(9):3249-52. PubMed ID: 2452203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC; Hargrove ME
    J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I; Miller SC
    Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T; Alm G; Stålhandshe T
    J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
    Sharma BS; Mhaskar S; Balazs L; Siaw M
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins.
    Voiculescu CL; Rosu L; Rogoz S
    Lymphology; 1988 Sep; 21(3):144-51. PubMed ID: 3264360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
    J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall.
    Scaringi L; Cornacchione P; Rosati E; Fettucciari K; Rossi R; Marconi P
    Cell Immunol; 1994 May; 155(2):265-82. PubMed ID: 8181065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor.
    Voth R; Rossol S; Gallati H; Pracht I; Laubenstein HP; Hess G; Müller WE; Schröder HC; Jochum C; Meyer zum Büschenfelde KH
    Cancer Immunol Immunother; 1988; 27(2):128-32. PubMed ID: 2458181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
    Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ.
    Lala PK; Parhar RS
    Cancer Res; 1988 Mar; 48(5):1072-9. PubMed ID: 3124954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW; Trimble WS; Hozumi N; Roder JC
    J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.
    Shimada S; Yano O; Tokunaga T
    Jpn J Cancer Res; 1986 Aug; 77(8):808-16. PubMed ID: 2428798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.
    Gibson PR; Jewell DP
    Clin Exp Immunol; 1985 Jul; 61(1):160-8. PubMed ID: 2412737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimetastatic activity induced by Clostridium butyricum and characterization of effector cells.
    Chen HY; Wu SL; Yeh MY; Chen CF; Mikami Y; Wu JS
    Anticancer Res; 1993; 13(1):107-11. PubMed ID: 8476200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
    Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O
    Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.